{
  "schemaType": "LegalCase",
  "title": "Depo-Provera / Meningioma",
  "shortName": "Depo-Provera",
  "slug": "depo-provera",
  "canonicalUrl": "https://tortsignals.lawtegic.solutions/torts/depo-provera",
  "description": "March 2024 BMJ study established a 5.6× increased meningioma risk for long-term Depo-Provera users. Pfizer faces failure-to-warn allegations. Massive plaintiff pool — Depo-Provera has been prescribed to tens of millions of women since 1992.",
  "body": "March 2024 BMJ study established a 5.6× increased meningioma risk for long-term Depo-Provera users. Pfizer faces failure-to-warn allegations. Massive plaintiff pool — Depo-Provera has been prescribed to tens of millions of women since 1992.",
  "tortSignalScore": 87,
  "opportunityScore": 85,
  "riskScore": 28,
  "mdl": "MDL 3140 (N.D. Cal.)",
  "docket": "MDL 3140 (N.D. Cal.)",
  "drugName": "Depo-Provera",
  "defendant": "Pfizer",
  "primaryInjury": "Intracranial meningioma (brain tumor)",
  "jurisdictionLead": "Northern California",
  "stage": "mid",
  "campaign": "OPEN",
  "caseValueRange": "$100K – $500K per qualifying claim",
  "litigationStatus": "MDL 3140 consolidated October 2024 in N.D. California. Active filings; no bellwether dates set. Strong science from peer-reviewed BMJ study supports causation.",
  "attorneyAction": "Aggressive intake recommended. Plaintiff pool is enormous and science is unusually strong for an early-stage MDL. Geographic priority: nationwide.",
  "qualifies": "Women who received ≥2 Depo-Provera shots and were later diagnosed with intracranial meningioma. Diagnosis must be confirmed by MRI/CT imaging.",
  "competition": "moderate",
  "recentNews": [
    {
      "date": "Apr 11, 2026",
      "source": "BMJ",
      "headline": "Updated meta-analysis confirms 5.6× meningioma risk in Depo-Provera users"
    },
    {
      "date": "Apr 03, 2026",
      "source": "Reuters",
      "headline": "Pfizer denies Depo-Provera labeling failure in MDL response"
    }
  ],
  "faq": [
    {
      "q": "What is the Depo-Provera lawsuit about?",
      "a": "Plaintiffs allege Pfizer failed to warn about a 5.6× increased risk of intracranial meningioma associated with long-term use of the Depo-Provera contraceptive injection."
    },
    {
      "q": "Who qualifies for a Depo-Provera meningioma claim?",
      "a": "Women who received two or more Depo-Provera injections and were subsequently diagnosed with an intracranial meningioma confirmed by MRI or CT imaging."
    },
    {
      "q": "What is the estimated case value?",
      "a": "Estimated case values range from $100,000 to $500,000 depending on tumor severity and whether surgical intervention was required."
    },
    {
      "q": "What is the litigation status?",
      "a": "MDL 3140 was consolidated in October 2024 in the Northern District of California. Filings are active; no bellwether trial dates have been set."
    },
    {
      "q": "What should attorneys do?",
      "a": "Open aggressive intake. The plaintiff pool is enormous and the underlying science is unusually strong for an early-stage MDL."
    }
  ],
  "publisher": {
    "name": "LawTegic Solutions Media",
    "brand": "TortSignal",
    "url": "https://tortsignals.lawtegic.solutions"
  },
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "updatedAt": "2026-06-18T21:15:13.663Z"
}